Firm News

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com

Cahill Represents ICON plc in its Acquisition of PMG Research

Date: 12/04/15

Cahill represented ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, in connection with its acquisition of PMG Research Inc., an integrated network of clinical research sites operating from 12 metropolitan areas throughout the US.  The acquisition will enhance ICON’s ability to access and engage with investigator sites and patients, helping customers to reduce the overall time and cost associated with drug development.

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com